|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/46 | (2006.01) |
| A61K 38/51 | (2006.01) | ||
| A61K 35/18 | (2015.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3397272 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17700008.0 |
| Date of filing the European patent application | 2017-01-02 | |
| (97) | Date of publication of the European application | 2018-11-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/050006 |
| Date | 2017-01-02 |
| (87) | Number | WO 2017/114966 |
| Date | 2017-07-06 |
| (30) | Number | Date | Country code |
| 15307197 | 2015-12-31 | EP |
| (72) |
AGUERA, Karine , FR
BERLIER, Willy , FR
GAY, Fabien , FR
GODFRIN, Yann , FR
|
| (73) |
Erytech Pharma ,
60 Avenue Rockefeller, 69008 Lyon,
FR
|
| (54) | METHIONINE AND ASPARAGINE DEPLETION FOR USE IN TREATING A CANCER |
| METHIONINE AND ASPARAGINE DEPLETION FOR USE IN TREATING A CANCER |